PETALING JAYA – Malaysia is set to produce its first locally made human vaccine as early as 2028.This marks a major step towards reducing reliance on imported vaccines and strengthening the country’s health security.The 13-valent pneumococcal conjugate vaccine, or PCV13, is an injection that protects against 13 types of Streptococcus pneumoniae bacteria which cause serious illnesses such as pneumonia and meningitis.The local company involved in the manufacturing of the vaccine is Pharmaniaga, with technology transfer from a company in China.At present, Malaysia imports all its vaccines, sourced from countries such as the United States, France, Belgium, Japan, South Korea, India,…